The three-year agreement calls for research collaborations focused on areas of excellence for both organizations: cancer; brain sciences; biomedical engineering, medical device and drug development; and geriatrics and long-term care.
The three-year agreement calls for research collaborations focused on areas of excellence for both organizations: cancer; brain sciences; biomedical engineering, medical device and drug development; and geriatrics and long-term care.